As shown in Figure 3A, shRNA knockdown of CPT1A or treatment with etomoxir for 24 hours induced significant increases in G0/G1 population with concomitant decreases in S and G2/M phases in all ovarian cancer cell lines examined. Here, CPT1A is linked to ovarian cancer.